REMGRO yesterday reported a 126.6% y/y rise in HEPS to 712cps, while headline earnings rose by 126.2% to R3.657bn in the HY to end-Dec. The company noted that, during the previous comparable period, MEDICLINIC had incurred material once-off charges relating to the comprehensive refinancing of its Swiss and South African debt. REMGRO’s share of these once-off items included in the results for H1 FY2012 had amounted to losses of R1.4bn. This news brief represents a summary of the original article. 10:54:00 19/03/2014